Skip Navigation


IJE Advance Access originally published online on January 4, 2006
International Journal of Epidemiology 2006 35(1):166-168; doi:10.1093/ije/dyi301
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
35/1/166    most recent
dyi301v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Webb, P. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webb, P. M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2006; all rights reserved.

Commentary

Commentary: Weight gain, weight loss, and endometrial cancer

Penelope M Webb

Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, Qld 4029, Australia. E-mail: Penny.webb@qimr.edu.au

The first 10% of the full text of this article appears below.

It has long been recognized that women who develop endometrial cancer are often overweight1 and obesity is now clearly established as a major risk factor for the disease.2 In pre-menopausal women, obesity is associated with an increased frequency of anovulatory cycles and, as a result, the endometrium is exposed to oestrogen in the absence of progesterone. Among post-menopausal women, obesity is again associated with exposure to higher levels of endogenous oestrogen as a result of increased conversion of androstenedione to oestrone in adipose tissue and lower levels of sex-hormone binding globulin (SHBG). In the absence of progesterone, unopposed oestrogen stimulates cellular proliferation in the endometrium leading to hyperplasia and, potentially, cancer.3

It has been estimated that up to 40% of all endometrial cancers could be related to obesity,2 a figure that is rising as the prevalence of obesity increases.4 More than 1.1 billion adults worldwide are now . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
Y. Wang, P. Hanifi-Moghaddam, E. E. Hanekamp, H. J. Kloosterboer, P. Franken, J. Veldscholte, H. C. van Doorn, P. C. Ewing, J. J. Kim, J. A. Grootegoed, et al.
Progesterone Inhibition of Wnt/{beta}-Catenin Signaling in Normal Endometrium and Endometrial Cancer
Clin. Cancer Res., September 15, 2009; 15(18): 5784 - 5793.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. C. Rodriguez, B.J. Rimel, W. Watkin, J. M. Turbov, C. Barry, H. Du, G. L. Maxwell, and J.M. Cline
Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-{beta} in the Uterine Endometrium
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 578 - 584.
[Abstract] [Full Text] [PDF]